Heart rate and ejection fraction as prognostic markers in recurrent pericarditis

Heart rate and ejection fraction as prognostic markers in recurrent pericarditis

Abstract Background Heart rate (HR) and left ventricular ejection fraction (LVEF) are both important markers in assessing symptom improvement in patients with recurrent pericarditis (RP). However, their prognostic significance in predicting RP outcomes remains largely unexplored, as no prior studies...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2023-11, Vol.44 (Supplement_2)
Hauptverfasser: Yesilyaprak, A, Kumar, A, Agrawal, A, Furqan, M, Verma, B, Akyuz, K, Syed, A, Majid, M, Wang, T, Cremer, P, Klein, A
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue Supplement_2
container_start_page
container_title European heart journal
container_volume 44
creator Yesilyaprak, A
Kumar, A
Agrawal, A
Furqan, M
Verma, B
Akyuz, K
Syed, A
Majid, M
Wang, T
Cremer, P
Klein, A
description Abstract Background Heart rate (HR) and left ventricular ejection fraction (LVEF) are both important markers in assessing symptom improvement in patients with recurrent pericarditis (RP). However, their prognostic significance in predicting RP outcomes remains largely unexplored, as no prior studies have investigated this relationship. Methods Patients with RP were identified from a pericardial database covering the period between 2012 and 2019. The outcome of interest was clinical remission, which was defined as the resolution of symptoms without any further recurrences after discontinuing all anti-inflammatory therapies. Results A total of 365 patients were included in this study, of which the majority were females (56%) and less than 55 years old (68%). The mean number of recurrences at baseline was ≥4 in 158 (43%) of patients. The time to clinical remission was 24 months in the low HR group (HR ≤ 70 bpm), 60 months in the moderate HR group (HR: 71-90 bpm), and could not be determined for the high HR group (HR ≥ 90 bpm) due to few events. Patients with LVEF < 60% took 56 months to achieve clinical remission, compared with patients with LVEF ≥ 60%, who took over 60 months. Multivariable analysis revealed that patients in the high (HR: 0.22, 95% CI: 0.09-0.51, p=
doi_str_mv 10.1093/eurheartj/ehad655.1798
format Article
fullrecord <record><control><sourceid>oup_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartj_ehad655_1798</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/eurheartj/ehad655.1798</oup_id><sourcerecordid>10.1093/eurheartj/ehad655.1798</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1378-165b44262aa376d3d8158dda79a3f9a9681f40e8ea066c646d0a238d835306323</originalsourceid><addsrcrecordid>eNqNkMFKAzEURYMoWKu_IPmBaZPJ5E2ylKK2UNCFgrvhmbyxqTozvEwX_r0tLa5d3bs5l8sR4larmVbezGnHG0Iet3PaYARrZ7r27kxMtC3LwkNlz8VEaW8LAPd2Ka5y3iqlHGiYiOflAZWMI0nsoqQthTH1nWwZjwWzHLj_6Po8piC_kT-Js0ydZAo7ZupGORCngBzTmPK1uGjxK9PNKafi9eH-ZbEs1k-Pq8Xdugja1K7QYN-rqoQS0dQQTXTauhix9mhajx6cbitFjlABBKggKiyNi85Yo8CUZirguBu4z5mpbQZO-3c_jVbNwUvz56U5eWkOXvagPoL9bvgv8wsF62wu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Heart rate and ejection fraction as prognostic markers in recurrent pericarditis</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Yesilyaprak, A ; Kumar, A ; Agrawal, A ; Furqan, M ; Verma, B ; Akyuz, K ; Syed, A ; Majid, M ; Wang, T ; Cremer, P ; Klein, A</creator><creatorcontrib>Yesilyaprak, A ; Kumar, A ; Agrawal, A ; Furqan, M ; Verma, B ; Akyuz, K ; Syed, A ; Majid, M ; Wang, T ; Cremer, P ; Klein, A</creatorcontrib><description>Abstract Background Heart rate (HR) and left ventricular ejection fraction (LVEF) are both important markers in assessing symptom improvement in patients with recurrent pericarditis (RP). However, their prognostic significance in predicting RP outcomes remains largely unexplored, as no prior studies have investigated this relationship. Methods Patients with RP were identified from a pericardial database covering the period between 2012 and 2019. The outcome of interest was clinical remission, which was defined as the resolution of symptoms without any further recurrences after discontinuing all anti-inflammatory therapies. Results A total of 365 patients were included in this study, of which the majority were females (56%) and less than 55 years old (68%). The mean number of recurrences at baseline was ≥4 in 158 (43%) of patients. The time to clinical remission was 24 months in the low HR group (HR ≤ 70 bpm), 60 months in the moderate HR group (HR: 71-90 bpm), and could not be determined for the high HR group (HR ≥ 90 bpm) due to few events. Patients with LVEF &lt; 60% took 56 months to achieve clinical remission, compared with patients with LVEF ≥ 60%, who took over 60 months. Multivariable analysis revealed that patients in the high (HR: 0.22, 95% CI: 0.09-0.51, p=&lt;0.001) and moderate (HR: 0.39, 95% CI: 0.21-0.75, p=0.005) HR groups were less likely to achieve clinical remission than those in the low HR group. Similarly, patients with LVEF ≥ 60% were less likely to achieve clinical remission than those with LVEF &lt; 60% (HR: 0.54, 95% CI: 0.36-0.80, p=0.002). Conclusion Both HR and LVEF play important roles in prognosticating outcomes in patients with RP. The significance of both markers can be attributed to the heightened shear stress on the pericardium, which can exacerbate inflammation.Multivariable analysis</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehad655.1798</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><ispartof>European heart journal, 2023-11, Vol.44 (Supplement_2)</ispartof><rights>The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Yesilyaprak, A</creatorcontrib><creatorcontrib>Kumar, A</creatorcontrib><creatorcontrib>Agrawal, A</creatorcontrib><creatorcontrib>Furqan, M</creatorcontrib><creatorcontrib>Verma, B</creatorcontrib><creatorcontrib>Akyuz, K</creatorcontrib><creatorcontrib>Syed, A</creatorcontrib><creatorcontrib>Majid, M</creatorcontrib><creatorcontrib>Wang, T</creatorcontrib><creatorcontrib>Cremer, P</creatorcontrib><creatorcontrib>Klein, A</creatorcontrib><title>Heart rate and ejection fraction as prognostic markers in recurrent pericarditis</title><title>European heart journal</title><description>Abstract Background Heart rate (HR) and left ventricular ejection fraction (LVEF) are both important markers in assessing symptom improvement in patients with recurrent pericarditis (RP). However, their prognostic significance in predicting RP outcomes remains largely unexplored, as no prior studies have investigated this relationship. Methods Patients with RP were identified from a pericardial database covering the period between 2012 and 2019. The outcome of interest was clinical remission, which was defined as the resolution of symptoms without any further recurrences after discontinuing all anti-inflammatory therapies. Results A total of 365 patients were included in this study, of which the majority were females (56%) and less than 55 years old (68%). The mean number of recurrences at baseline was ≥4 in 158 (43%) of patients. The time to clinical remission was 24 months in the low HR group (HR ≤ 70 bpm), 60 months in the moderate HR group (HR: 71-90 bpm), and could not be determined for the high HR group (HR ≥ 90 bpm) due to few events. Patients with LVEF &lt; 60% took 56 months to achieve clinical remission, compared with patients with LVEF ≥ 60%, who took over 60 months. Multivariable analysis revealed that patients in the high (HR: 0.22, 95% CI: 0.09-0.51, p=&lt;0.001) and moderate (HR: 0.39, 95% CI: 0.21-0.75, p=0.005) HR groups were less likely to achieve clinical remission than those in the low HR group. Similarly, patients with LVEF ≥ 60% were less likely to achieve clinical remission than those with LVEF &lt; 60% (HR: 0.54, 95% CI: 0.36-0.80, p=0.002). Conclusion Both HR and LVEF play important roles in prognosticating outcomes in patients with RP. The significance of both markers can be attributed to the heightened shear stress on the pericardium, which can exacerbate inflammation.Multivariable analysis</description><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqNkMFKAzEURYMoWKu_IPmBaZPJ5E2ylKK2UNCFgrvhmbyxqTozvEwX_r0tLa5d3bs5l8sR4larmVbezGnHG0Iet3PaYARrZ7r27kxMtC3LwkNlz8VEaW8LAPd2Ka5y3iqlHGiYiOflAZWMI0nsoqQthTH1nWwZjwWzHLj_6Po8piC_kT-Js0ydZAo7ZupGORCngBzTmPK1uGjxK9PNKafi9eH-ZbEs1k-Pq8Xdugja1K7QYN-rqoQS0dQQTXTauhix9mhajx6cbitFjlABBKggKiyNi85Yo8CUZirguBu4z5mpbQZO-3c_jVbNwUvz56U5eWkOXvagPoL9bvgv8wsF62wu</recordid><startdate>20231109</startdate><enddate>20231109</enddate><creator>Yesilyaprak, A</creator><creator>Kumar, A</creator><creator>Agrawal, A</creator><creator>Furqan, M</creator><creator>Verma, B</creator><creator>Akyuz, K</creator><creator>Syed, A</creator><creator>Majid, M</creator><creator>Wang, T</creator><creator>Cremer, P</creator><creator>Klein, A</creator><general>Oxford University Press</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20231109</creationdate><title>Heart rate and ejection fraction as prognostic markers in recurrent pericarditis</title><author>Yesilyaprak, A ; Kumar, A ; Agrawal, A ; Furqan, M ; Verma, B ; Akyuz, K ; Syed, A ; Majid, M ; Wang, T ; Cremer, P ; Klein, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1378-165b44262aa376d3d8158dda79a3f9a9681f40e8ea066c646d0a238d835306323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yesilyaprak, A</creatorcontrib><creatorcontrib>Kumar, A</creatorcontrib><creatorcontrib>Agrawal, A</creatorcontrib><creatorcontrib>Furqan, M</creatorcontrib><creatorcontrib>Verma, B</creatorcontrib><creatorcontrib>Akyuz, K</creatorcontrib><creatorcontrib>Syed, A</creatorcontrib><creatorcontrib>Majid, M</creatorcontrib><creatorcontrib>Wang, T</creatorcontrib><creatorcontrib>Cremer, P</creatorcontrib><creatorcontrib>Klein, A</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yesilyaprak, A</au><au>Kumar, A</au><au>Agrawal, A</au><au>Furqan, M</au><au>Verma, B</au><au>Akyuz, K</au><au>Syed, A</au><au>Majid, M</au><au>Wang, T</au><au>Cremer, P</au><au>Klein, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Heart rate and ejection fraction as prognostic markers in recurrent pericarditis</atitle><jtitle>European heart journal</jtitle><date>2023-11-09</date><risdate>2023</risdate><volume>44</volume><issue>Supplement_2</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Abstract Background Heart rate (HR) and left ventricular ejection fraction (LVEF) are both important markers in assessing symptom improvement in patients with recurrent pericarditis (RP). However, their prognostic significance in predicting RP outcomes remains largely unexplored, as no prior studies have investigated this relationship. Methods Patients with RP were identified from a pericardial database covering the period between 2012 and 2019. The outcome of interest was clinical remission, which was defined as the resolution of symptoms without any further recurrences after discontinuing all anti-inflammatory therapies. Results A total of 365 patients were included in this study, of which the majority were females (56%) and less than 55 years old (68%). The mean number of recurrences at baseline was ≥4 in 158 (43%) of patients. The time to clinical remission was 24 months in the low HR group (HR ≤ 70 bpm), 60 months in the moderate HR group (HR: 71-90 bpm), and could not be determined for the high HR group (HR ≥ 90 bpm) due to few events. Patients with LVEF &lt; 60% took 56 months to achieve clinical remission, compared with patients with LVEF ≥ 60%, who took over 60 months. Multivariable analysis revealed that patients in the high (HR: 0.22, 95% CI: 0.09-0.51, p=&lt;0.001) and moderate (HR: 0.39, 95% CI: 0.21-0.75, p=0.005) HR groups were less likely to achieve clinical remission than those in the low HR group. Similarly, patients with LVEF ≥ 60% were less likely to achieve clinical remission than those with LVEF &lt; 60% (HR: 0.54, 95% CI: 0.36-0.80, p=0.002). Conclusion Both HR and LVEF play important roles in prognosticating outcomes in patients with RP. The significance of both markers can be attributed to the heightened shear stress on the pericardium, which can exacerbate inflammation.Multivariable analysis</abstract><cop>US</cop><pub>Oxford University Press</pub><doi>10.1093/eurheartj/ehad655.1798</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2023-11, Vol.44 (Supplement_2)
issn 0195-668X
1522-9645
language eng
recordid cdi_crossref_primary_10_1093_eurheartj_ehad655_1798
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
title Heart rate and ejection fraction as prognostic markers in recurrent pericarditis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T16%3A46%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-oup_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Heart%20rate%20and%20ejection%20fraction%20as%20prognostic%20markers%20in%20recurrent%20pericarditis&rft.jtitle=European%20heart%20journal&rft.au=Yesilyaprak,%20A&rft.date=2023-11-09&rft.volume=44&rft.issue=Supplement_2&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehad655.1798&rft_dat=%3Coup_cross%3E10.1093/eurheartj/ehad655.1798%3C/oup_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_oup_id=10.1093/eurheartj/ehad655.1798&rfr_iscdi=true